IL17A and psoriasis: To evaluate the potential pharmacological effect of PUN on psoriasis, we made use of imiquimod (IMQ)-induced psoriasis-like mice model and tumor necrosis factor α (TNF-α) and IL-17A-stimulated HaCaT cells.